KAEL Gemvax
May 04, 2015
Telomerase Inhibitors – An Anti Cancer Approach
The current cancer therapies and drug design strategies developed are more precisely aimed at targeting the cancer cells. Primary challenge in selectively targeting cancer cells is to differentiate between the cancer cells and the normal cells. One such difference is enzyme telomerase activity which has been an exc...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
